Related Experiment Videos
Liposomes as drug carriers: a technological approach
1Univesitetet i Tromsø, Institutt for Farmasi, Avdeling for Galenisk Farmasi, N-9037 Tromsø, Norway.
Biotechnology Annual Review
|November 1, 2001
Summary
Liposome drug carriers, despite extensive research, face challenges in clinical approval due to manufacturing limitations. This review critically examines technologies for liposome preparation, characterization, and stability for therapeutic applications.
Area of Science:
- Pharmaceutical Sciences
- Biotechnology
- Drug Delivery
Background:
- Liposomes are versatile drug carriers developed over three decades.
- Numerous liposomal formulations exist, primarily from small-scale laboratory methods.
- Limited liposomal preparations have achieved regulatory approval for human use.
Purpose of the Study:
- To critically review key technologies for liposome development.
- To address challenges in scaling up liposome production.
- To evaluate aspects of liposome quality and stability for clinical translation.
Main Methods:
- Literature survey of established and emerging liposome technologies.
- Analysis of methods for lipid formulation evaluation.
- Review of techniques for liposome preparation, sizing, loading, and sterilization.
Main Results:
- Identified critical technologies for reproducible liposome manufacturing.
- Highlighted the importance of raw material definition and process control.
- Discussed quality control and shelf-life considerations for liposomal drug carriers.
Conclusions:
- Bridging the gap between laboratory synthesis and clinical application requires robust manufacturing technologies.
- Standardized methods are crucial for ensuring the safety and efficacy of liposomal drugs.
- Further research into scalable and GMP-compliant liposome production is essential.